Antiviral Drugs Global Market Report 2022: Featuring Key Players AbbVie, GlaxoSmithKline, Merck, Pfizer & More
DUBLIN, Dec. 5, 2022 /PRNewswire/ -- The "Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target,…
152,880€
1,08%
Echtzeit-Aktienkurs ABBVIE
Bid:
Ask:
Nachrichten zur ABBVIE Aktie
HIV treatment drugs market in Africa: Growth Opportunities led by Abbott Laboratories and AbbVie Inc. - Technavio
NEW YORK, Dec. 5, 2022 /PRNewswire/ -- The HIV treatment drugs market size in Africa is forecast to grow by…
Is AbbVie Stock a Smart Contrarian Pick for 2023?
The pharma giants story wont be over with anticipated sales declines for its top-selling drug....…
AbbVie Stock Has Climbed a Wall of Humira Worry. Why There’s Still Time to Buy.
Abbvie has racked up nearly $200 billion in Humira sales, but it has lost patent protection in Europe and faces…
Outlook on the Psoriatic Arthritis Treatment Global Market to 2027 - Players Include AbbVie, Johnson & Johnson, UCB, Amgen and Bristol-Myers Squibb
DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027" report has…
AbbVie gets reimbursement for Rinvoq in 5 Canadian provinces
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie Announces Provincial Reimbursement For RINVOQ For Rheumatoid Treatment
WASHINGTON (dpa-AFX) - AbbVie Inc. (ABBV) Thursday announced provincial reimbursement for RINVOQ for the treatment of rheumatoid arthritis and psoriatic…
United States Pharmaceutical Industry Industry Report 2022 Featuring Abbot Laboratories, AbbVie, Allergan, Amgen, BMS, Eli Lilly and Co, Gilead Sciences, GSK, Johnson & Johnson, Merck, Pfizer, & Teva
DUBLIN, Nov. 29, 2022 /PRNewswire/ -- The "Pharmaceutical Industry in the United States 2022" report has been added to ResearchAndMarkets.coms…
Multiple Myeloma Drugs Market: Growth Opportunities led by Abbott Laboratories and AbbVie Inc. - Technavio
NEW YORK, Nov. 28, 2022 /PRNewswire/ -- The multiple myeloma drugs market size is estimated to grow by USD 6,419.94…
Better Dividend Stock: AbbVie or Viatris?
These pharmaceutical companies are profitable and offer above-average dividends....…
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
This is a stock that rewards long-term investors through continual dividend increases....…
World Clinical Trials Racial Representation Data Study 2022 Featuring Novartis, GSK, Pfizer, Johnson & Johnson, AstraZeneca, F. Hoffmann-La Roche, Eli Lilly, Merck & Co, AbbVie, & Bayer
DUBLIN, Nov. 23, 2022 /PRNewswire/ -- The "Clinical Trials - The Importance of Diversity in Clinical Trials" report has been…
AbbVie to Present at the Evercore ISI HealthCONx Conference
NORTH CHICAGO, Ill., Nov. 23, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 5th Annual Evercore ISI Virtual…
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year....…
AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting
- Nearly 65 abstracts, including 15 oral presentations on 7 investigational and approved medicines across 8 cancer types, to be…
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
read more...…
Top Stock Reports for AbbVie, PepsiCo & Walt Disney
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), PepsiCo, Inc. (PEP) and The…
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements
...By Brendan Pierson
(Reuters) - Teva Pharmaceutical Industries Ltd......…
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
The pharmaceutical companys golden goose is about to stop laying golden eggs, but that wont be a permanent problem....…
AbbVie, Genmab lymphoma therapy goes under FDA priority review
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie: FDA To Review BLA For Epcoritamab
COPENHAGEN (dpa-AFX) - AbbVie (ABBV) announced the FDA has accepted for priority review the Biologics License Application for epcoritamab, an…
AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma
AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma...…
Meta, AbbVie among new names in UBS 2023 stock focus list
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Where AbbVie Stands With Analysts
Latest Ratings for ABBV
DateFirmActionFromTo Feb 2022UBSDowngradesBuyNeutral Feb 2022MizuhoMaintainsBuy Feb 2022BarclaysMaintainsEqual-Weight
View More Analyst Ratings…
AMCP Foundation Interns Delve into Oncology, Evidence Gaps, Medication Adherence in Partnership with AbbVie Inc. and Pfizer Inc.
ALEXANDRIA, Va., Nov. 17, 2022 /PRNewswire/ -- AMCP Foundation congratulates the student pharmacists who recently completed immersive managed care centered…
Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Most Successful One Yet
A RECORD-BREAKING NUMBER OF CONSUMERS PARTICIPATED, WITH BOGO GIFT CARDS SELLING OUT IN JUST A FEW HOURS11 IRVINE, Calif., Nov.…
AbbVie Presents Data from Extensive Portfolio at the American College of Rheumatology Convergence 2022
Thirty-six abstracts underscore AbbVies commitment to advancing research to help more people living with rheumatic diseases Additional analysis of long-term…
AbbVie downgraded to hold at Societe Generale on weakness in blood cancer, aesthetics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie: Phase 2 Trial Of AGN-151607 In POAF In Cardiac Surgery Patients Fails To Meet Main Goal
WASHINGTON (dpa-AFX) - AbbVie (ABBV) announced results from its exploratory NOVA phase 2 dose-ranging study evaluating the efficacy and safety…
AbbVie candidate for postoperative atrial fibrillation fails in mid-stage trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
3 Reasons to Buy AbbVie Stock Right Now
The drugmaker has something to offer to all kinds of investors....…
Form 10-Q AbbVie Inc. For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Better Buy: AbbVie vs. Walgreens Boots Alliance
Both these companies pay a dividend, but the similarities stop there....…
REGENXBIO Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
Continued progress on 5x25 strategy to advance five AAV Therapeutics from our internal pipeline and licensed programs into pivotal-stage or…
Why Dividend Investors Can Still Buy AbbVie Stock With No Worries
The big-pharma companys dividend remains safe and sound....…
6 Stocks With Healthy Dividends and Solid Returns
AbbVie, Gilead Sciences, Cardinal Health, Merck, Bristol Myers, and Amgen are large-cap healthcare companies that have the capacity to grow…
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…